Cancer Chemoprevention: Classic and Epigenetic Mechanisms Inhibiting Tumorigenesis. What Have We Learned So Far?

Frontiers in Oncology - Switzerland
doi 10.3389/fonc.2018.00644
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers Media SA

Related search

What Have We Learned, So Far?

Prehospital and Disaster Medicine
Emergency NursingEmergency Medicine
2002English

Campylobacter Phage Isolation and Characterization: What We Have Learned So Far

Methods and Protocols
2019English

Transcriptomics of Cereal-Fusarium Graminearum Interactions: What We Have Learned So Far

Molecular Plant Pathology
Plant ScienceAgronomySoil ScienceCrop ScienceMolecular Biology
2017English

Mitochondrial Neurogastrointestinal Encephalomyopathy: Into the Fourth Decade, What We Have Learned So Far

Frontiers in Genetics
GeneticsMolecular Medicine
2018English

Neurotoxicity, General Anesthesia, and the Developing Brain: What Have We Learned From the Human Studies So Far?

Current Anesthesiology Reports
AnesthesiologyPain Medicine
2013English

Tau Imaging in Parkinsonism - What Have We Learnt So Far?

Movement Disorders Clinical Practice
Neurology
2018English

Indian Ocean Tsunami: What Have We Learned So Far? What Do We Need to Know—Application of the Utstein Guidelines and Templates

Prehospital and Disaster Medicine
Emergency NursingEmergency Medicine
2005English

EuReCa_Serbia: What Have We Learned?

Journal Resuscitatio Balcanica
2019English

What We Have Learned and How We May Proceed

International Studies in Entrepreneurship
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy